PT559 – The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections, with Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, and Michael Baime, MD
Description
In this episode, Joe interviews 4 members of the Penn Psychedelics Collaborative: Co-Founder, Taylor Andrews Flatt, PMHNP; Associate Director, Victor Pablo Acero, Ph.D.; Professor in Fine Arts and Co-Director of the Weitzman School of Design, Jackie Tileston; and Executive Director and Director of the Penn Program for Mindfulness, Michael Baime, MD.
Recorded earlier this month at the PhilaDelic conference – one of the primary initiatives of the PPC – they discuss their paths to psychedelics and why this transdisciplinary collection of faculty, researchers, and clinicians at the University of Pennsylvania was so necessary. Viewing psychedelics from different perspectives (Flatt from nursing, Acero from bioengineering, Tileston from the art and mysticism side of things, and Baime from a more mindfulness point of view), their group is a case study in collaboration – a place where connections can be catalyzed and shared goals can be addressed from different angles. How far can we go when different groups start working together?
They discuss:
The concept of psychedelics not just being used to treat conditions, but to make us healthier Psychedelic art and the idea of the art itself being psychoactive rather than just representations of trips The work of David Glowacki and bringing about non-ordinary states of consciousness through VR Research into salvia being used to alleviate stroke symptoms How a lack of funding can really create focus and more!
For links, head to the show notes page.
In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketamine-assisted therapy and psychedelic integration.
He talks about what he feels is one of the...
Published 11/15/24
In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico.
When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for treatment. So...
Published 11/11/24